Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT05940324

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Led by Stanford University · Updated on 2026-04-24

150

Participants Needed

1

Research Sites

244 weeks

Total Duration

On this page

Sponsors

S

Stanford University

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

CONDITIONS

Official Title

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 18 to 65
  • Meet the criteria for OCD diagnosis
  • Failed at least 1 prior trial of standard first-line OCD treatment
  • Agree to lifestyle modifications including fasting before the experimental session, no enrollment in other interventional trials during the study, and commitment to medication study procedures
  • Able to provide informed consent
  • Healthy volunteers aged 18 to 65 able to provide informed consent
Not Eligible

You will not qualify if you...

  • Prior use or exposure to naltrexone or ketamine
  • Any current or past medical or psychiatric condition making participation unsafe as judged by the investigator or study physician
  • Pregnant or nursing, or able to become pregnant and not using effective birth control
  • Presence of metal in the body contraindicated for MRI scans
  • Current or past use of psychotropic medication in healthy volunteers
  • Pregnant or nursing females among healthy volunteers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Psychiatry & Behavioral Sciences

Stanford, California, United States, 94305

Actively Recruiting

Loading map...

Research Team

P

Pavithra Mukunda, MS

CONTACT

C

Carolyn I Rodriguez, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here